Asset Details
Do you wish to reserve the book?
General practitioners’ attitudes and behaviors toward HPV vaccination: A French national survey
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
General practitioners’ attitudes and behaviors toward HPV vaccination: A French national survey
Do you wish to request the book?
General practitioners’ attitudes and behaviors toward HPV vaccination: A French national survey
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
General practitioners’ attitudes and behaviors toward HPV vaccination: A French national survey
2016
Overview
•We assessed French GPs’ attitudes and behaviors about HPV vaccination.•HPV vaccine hesitancy is fairly prevalent among GPs.•Perception of the vaccine risk-benefit balance is the strongest determinant of this behavior.
General practitioners (GPs) play a crucial role in human papillomavirus (HPV) vaccine acceptance in France. We sought to study: (1) GPs’ perceptions of its risks and efficacy and their recommendation behavior; (2) the relative importance of factors associated with the frequency of their recommendations.
Cross-sectional observational study in 2014 nested in a national panel of 1712 randomly selected GPs in private practice in France (response rate: 92.4%). We used model averaging to analyze the associations of self-reported frequency of GPs’ HPV vaccine recommendations with their perception of its risk-benefit balance and their opinions about the utility of vaccines in general.
Overall, 72% of participants reported frequently recommending HPV vaccination; 60% considered that not enough is known about its risks. The model averaging showed that the factors most associated with infrequent recommendation of this vaccine by GPs were: unfavorable perceptions of its risk-benefit balance (OR=0.13; 95%CI=0.09–0.21; partial R2=0.10), a decision not to vaccinate one's own daughter(s) with this vaccine (OR=0.13; 95%CI=0.07–0.24; partial R2=0.05), and doubts about vaccine utility in general (OR=0.78; 95%CI=0.71–0.86; partial R2=0.03).
Although nearly three-quarters of French GPs frequently recommended the HPV vaccine, our findings indicate that a substantial percentage of them are hesitant about it. Doubts about its risks and efficacy strongly influence their recommendation behavior. More research is warranted to help design and evaluate tailored tools and multicomponent intervention strategies to address physician's hesitancy about this vaccine.
Publisher
Elsevier Ltd,Elsevier Limited,Elsevier
Subject
/ Attitude of Health Personnel
/ Female
/ France
/ General Practitioners - psychology
/ Humans
/ Male
/ Papillomavirus Infections - prevention & control
/ Papillomavirus Vaccines - therapeutic use
/ Practice Patterns, Physicians
/ Practice Patterns, Physicians' - statistics & numerical data
/ risk
/ Santé publique et épidémiologie
/ Vaccines
